These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 27196480

  • 1. Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy.
    Lee YC, Hsiao CY, Hung MC, Hung SC, Wang HP, Huang YJ, Wang JT.
    Medicine (Baltimore); 2016 May; 95(20):e3694. PubMed ID: 27196480
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictive factors for Enterococcus faecalis in complicated community-acquired urinary tract infections in older patients.
    Madrazo M, Esparcia A, Alberola J, Ferrer A, Eiros JM, Nogueira JM, Artero A.
    Geriatr Gerontol Int; 2020 Mar; 20(3):183-186. PubMed ID: 31876112
    [Abstract] [Full Text] [Related]

  • 4. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
    Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF.
    BMC Infect Dis; 2017 Apr 17; 17(1):279. PubMed ID: 28415969
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy.
    Burnham JP, Lane MA, Kollef MH.
    Crit Care Med; 2015 Aug 17; 43(8):1580-6. PubMed ID: 25855900
    [Abstract] [Full Text] [Related]

  • 7. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
    Stupica D, Lusa L, Klevišar MN, Terzić S, Pirš M, Premru MM, Strle F.
    Int J Antimicrob Agents; 2017 Oct 17; 50(4):564-571. PubMed ID: 28711676
    [Abstract] [Full Text] [Related]

  • 8. Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract Infection.
    Rieger KL, Bosso JA, MacVane SH, Temple Z, Wahlquist A, Bohm N.
    Pharmacotherapy; 2017 Nov 17; 37(11):1479-1483. PubMed ID: 28869655
    [Abstract] [Full Text] [Related]

  • 9. Mortality impact of empirical antimicrobial therapy in ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital.
    Lim CL, Spelman D.
    Infect Dis Health; 2019 Aug 17; 24(3):124-133. PubMed ID: 30928569
    [Abstract] [Full Text] [Related]

  • 10. Infection in cirrhosis: A prospective study.
    Bhattacharya C, Das-Mondal M, Gupta D, Sarkar AK, Kar-Purkayastha S, Konar A.
    Ann Hepatol; 2019 Aug 17; 18(6):862-868. PubMed ID: 31635968
    [Abstract] [Full Text] [Related]

  • 11. A Cohort Study of the Impact of Carbapenem-Resistant Enterobacteriaceae Infections on Mortality of Patients Presenting with Sepsis.
    Sabino S, Soares S, Ramos F, Moretti M, Zavascki AP, Rigatto MH.
    mSphere; 2019 Apr 10; 4(2):. PubMed ID: 30971443
    [Abstract] [Full Text] [Related]

  • 12. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.
    Zilberberg MD, Shorr AF, Micek ST, Vazquez-Guillamet C, Kollef MH.
    Crit Care; 2014 Nov 21; 18(6):596. PubMed ID: 25412897
    [Abstract] [Full Text] [Related]

  • 13. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F, Jia XQ, Zhao QG, Zhang Y.
    Ann Clin Microbiol Antimicrob; 2018 Mar 23; 17(1):13. PubMed ID: 29571291
    [Abstract] [Full Text] [Related]

  • 14. The clinical impact of bacteremia in complicated acute pyelonephritis.
    Hsu CY, Fang HC, Chou KJ, Chen CL, Lee PT, Chung HM.
    Am J Med Sci; 2006 Oct 23; 332(4):175-80. PubMed ID: 17031242
    [Abstract] [Full Text] [Related]

  • 15. Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children.
    Ivády B, Kenesei É, Tóth-Heyn P, Kertész G, Tárkányi K, Kassa C, Ujhelyi E, Mikos B, Sápi E, Varga-Heier K, Guóth G, Szabó D.
    Infection; 2016 Jun 23; 44(3):309-21. PubMed ID: 26546372
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.
    Russo A, Giuliano S, Ceccarelli G, Alessandri F, Giordano A, Brunetti G, Venditti M.
    Antimicrob Agents Chemother; 2018 Jun 23; 62(6):. PubMed ID: 29555630
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW, Trivedi T, Montgomery M, Petrovic DF, Yamaji R, Riley L.
    Ann Emerg Med; 2018 Oct 23; 72(4):449-456. PubMed ID: 29980462
    [Abstract] [Full Text] [Related]

  • 19. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
    Chen CY, Chen YH, Lu PL, Lin WR, Chen TC, Lin CY.
    J Microbiol Immunol Infect; 2012 Jun 23; 45(3):228-36. PubMed ID: 22572004
    [Abstract] [Full Text] [Related]

  • 20. Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials.
    Burnham JP, Micek ST, Kollef MH.
    PLoS One; 2017 Jun 23; 12(7):e0180247. PubMed ID: 28678812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.